Information card for entry 2312353
| Formula |
C26 H30 N2 O2 |
| Calculated formula |
C26 H30 N2 O2 |
| Title of publication |
A drug-drug cocrystal and a co-amorphous form, prepared from honokiol and ligustrazine, inspired by Chinese patent medicine. |
| Authors of publication |
Zhang, Yanli; Liu, Hui; Chen, Zongxin; Meng, Jialei; Li, Yunfeng; Qi, Luyao; Zhang, Suiliang; Chen, Xiaofeng; Lei, Ming |
| Journal of publication |
Acta crystallographica Section B, Structural science, crystal engineering and materials |
| Year of publication |
2023 |
| Journal volume |
79 |
| Journal issue |
6 |
| a |
8.0045 ± 0.0005 Å |
| b |
9.2035 ± 0.0006 Å |
| c |
15.821 ± 0.001 Å |
| α |
90.211 ± 0.002° |
| β |
102.112 ± 0.002° |
| γ |
93.805 ± 0.002° |
| Cell volume |
1136.88 ± 0.13 Å3 |
| Cell temperature |
170 K |
| Ambient diffraction temperature |
170 K |
| Number of distinct elements |
4 |
| Space group number |
2 |
| Hermann-Mauguin space group symbol |
P -1 |
| Hall space group symbol |
-P 1 |
| Residual factor for all reflections |
0.149 |
| Residual factor for significantly intense reflections |
0.0692 |
| Weighted residual factors for significantly intense reflections |
0.1332 |
| Weighted residual factors for all reflections included in the refinement |
0.1748 |
| Goodness-of-fit parameter for all reflections included in the refinement |
1.056 |
| Diffraction radiation wavelength |
0.71073 Å |
| Diffraction radiation type |
MoKα |
| Has coordinates |
Yes |
| Has disorder |
No |
| Has Fobs |
Yes |
For the version history of this entry, please navigate to main COD server.
The link is:
https://www.crystallography.net/2312353.html
